Low-dose aspirin for reduction in preeclampsia risk in high-risk women in Japan.

Low-dose aspirin for reduction in preeclampsia risk in high-risk women in Japan. - Low-dose aspirin for reduction in preeclampsia risk

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020013

Enrollment

600

Registered

2015-12-01

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Interventions

initiation of low-dose aspirin started from 12 to 16 weeks gestation and terminated below 28 weeks gestation no initiation of low-dose aspirin to control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: women who first visit before 16weeks gestation at our center and meet a criterion for the following lists 1 previous preeclampsia 2 chronich hypertension 3 diabetes 4 autoimmune disease 5 blood pressure>130/80 at the first visit 6 BMI greater than 35

Exclusion criteria

Exclusion criteria: 1 multiple pregnancy 2 non-Japanease 3 low-dose aspirin initiated under 12 weeks'gestation for other reason 4 women who are out of sympathy with a plan

Design outcomes

Primary

Measure	Time frame
the incidence of preeclampsia in high-risk women(previous preeclampsia,chronic hypertension,diabetes,autoimmune disease,blood pressure>130/80 at the first visit and BMI greater than 35)	—

Secondary

Measure	Time frame
the incidence of severe preeclampsia,preterm labor and fetal growth restriction in high-risk women	—

Countries

Japan

Contacts

Public ContactHaruna Kawaguchi

Osaka Medical Center and Research Institute for Maternal and Child Health the Department of Maternal Fetal Medicine

haruna@mch.pref.osaka.jp0725-56-1220

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026